{"product_id":"bpc157-10mg-tb500-10-mg","title":"BPC157 10mg + TB500 10 mg","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eBPC-157 + TB-500 — Advanced Tissue Repair \u0026amp; Regenerative Research Peptide Blend\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eRegenerative Biology | Tissue Repair Research | Cellular Migration | Angiogenesis | Inflammatory Signaling\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBPC-157 + TB-500 is an experimental peptide combination investigated for its potential involvement in tissue repair, cellular regeneration, inflammatory signaling, and wound-healing mechanisms.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCommonly referred to in bodybuilding and biohacking communities as the \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e“Wolverine Peptide Blend,”\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e this combination brings together two synthetic peptides associated with distinct biological research pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBPC-157 (Body Protection Compound-157)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e is a synthetic 15-amino-acid peptide studied primarily in preclinical models involving gastrointestinal tissues, tendons, ligaments, skeletal muscle, and wound repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eTB-500\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e is an experimental peptide associated with thymosin beta-4, a naturally occurring protein involved in actin regulation, cellular migration, and tissue repair processes. TB-500 is commonly identified as a seven-amino-acid fragment of thymosin beta-4 rather than the complete protein.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe combination has generated scientific interest because the peptides are associated with potentially complementary biological pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHowever, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eclinical synergy, accelerated recovery, and improved tissue regeneration have not been demonstrated in adequately controlled human trials\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProposed Mechanisms of Action\u003c\/span\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cspan\u003eBPC-157 — Tissue Repair \u0026amp; Cellular Signaling\u003c\/span\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003ePreclinical investigations have explored several potential biological mechanisms:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAngiogenesis:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of pathways associated with new blood vessel formation during tissue repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eTendon \u0026amp; Ligament Biology:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Animal studies have explored its possible influence on connective tissue healing and cellular organization.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInflammatory Signaling:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Experimental research suggests possible modulation of selected inflammatory pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGastrointestinal Tissue Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Preclinical investigations have examined mucosal protection and repair mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCellular Repair:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Studies have explored interactions with signaling pathways involved in cell migration and tissue remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese findings are predominantly derived from animal and laboratory studies.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cspan\u003eTB-500 — Actin Regulation \u0026amp; Cellular Migration\u003c\/span\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eResearch involving thymosin beta-4 and its related fragments has investigated biological processes associated with tissue regeneration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eActin-Related Signaling:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Examination of molecular interactions involving the actin cytoskeleton.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCellular Migration:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of mechanisms that influence cellular movement during tissue remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAngiogenesis Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Exploration of vascular development pathways, primarily in studies involving full-length thymosin beta-4.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eWound-Healing Biology:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of biological processes associated with tissue organization and repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInflammatory Response:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Experimental research into signaling pathways involved in tissue injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eScientific Clarification:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Findings involving full-length thymosin beta-4 cannot automatically be attributed to the shorter TB-500 fragment.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eCombined Peptide Research\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eThe theoretical interest in BPC-157 + TB-500 comes from the possibility of investigating complementary cellular mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003cspan\u003eResearch Area\u003c\/span\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cspan\u003eBPC-157\u003c\/span\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cspan\u003eTB-500\u003c\/span\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003ePrimary Research Focus\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eTissue protection and repair signaling\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eActin-related cellular biology\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eTendon \u0026amp; Ligament Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003ePredominantly animal studies\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eLimited direct evidence\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eMuscle Repair\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003ePreclinical investigation\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eRelated thymosin beta-4 research\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eAngiogenesis\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eExperimental vascular signaling\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003ePrimarily full-length thymosin beta-4 studies\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eInflammatory Signaling\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003ePreclinical modulation\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eExperimental investigation\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eHuman Clinical Efficacy\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eNot established\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eNot established\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eCombination Safety\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eNot established\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eNot established\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cspan\u003eThe hypothesis that BPC-157 acts locally while TB-500 produces systemic regenerative effects has not been adequately validated in humans.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003ePotential Research Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e1. Skeletal Muscle Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInvestigation of biological pathways involved in skeletal muscle injury responses, cellular adaptation, and tissue remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e2. Tendon \u0026amp; Ligament Biology\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExploration of molecular processes associated with connective tissue integrity and repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e3. Wound-Healing Mechanisms\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStudy of cellular migration, extracellular matrix organization, and tissue repair signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e4. Angiogenesis Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInvestigation of vascular signaling pathways associated with tissue regeneration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e5. Inflammatory Response\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExamination of experimental mechanisms involved in inflammation and cellular responses to tissue injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e6. Gastrointestinal Tissue Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInvestigation of BPC-157-related mechanisms in experimental models of gastrointestinal mucosal injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e7. Combination Pharmacology\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExploration of potential interactions between distinct peptide signaling pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese applications represent \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eexperimental research objectives rather than established therapeutic indications\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eScientific Evidence \u0026amp; Limitations\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eResearch involving BPC-157, thymosin beta-4, and TB-500 has produced findings of interest in regenerative biology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHowever, significant limitations remain:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eMost relevant evidence comes from laboratory experiments and animal models.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eHuman clinical efficacy data for BPC-157 are extremely limited.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eDirect human safety and efficacy evidence specific to TB-500 is insufficient.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eNo adequately controlled human trials have established the benefits of the combined formulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eImprovements in tendon healing, muscular recovery, mobility, or postoperative healing have not been clinically validated.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eThere is no established evidence that the combination treats chronic pain, tendinitis, or gastrointestinal ulcers in humans.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eOptimal formulation characteristics, pharmacokinetics, and long-term safety remain unknown.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eResearch Conclusion:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e The combination offers a subject for experimental investigation, but the available evidence does not support claims of proven regenerative synergy or accelerated recovery in humans.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eRegulatory Status \u0026amp; Anti-Doping Considerations\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBPC-157 and TB-500 are not FDA-approved medications for human therapeutic use.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNeither compound has an established regulatory approval for treating sports injuries, chronic pain, muscle damage, or postoperative recovery.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBoth substances are also prohibited under the World Anti-Doping Agency (WADA) regulations:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBPC-157:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Classified under S0 — Non-Approved Substances.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eTB-500:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Covered under S2 — Peptide Hormones, Growth Factors, Related Substances, and Mimetics.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese restrictions apply both in and out of competition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch-use labeling does not exempt athletes from anti-doping regulations.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eSafety \u0026amp; Potential Risks\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eHuman safety information for this combination remains inadequate.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePotential concerns include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImmunogenicity:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Synthetic peptides may trigger unwanted immune responses.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct Purity:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Research materials may contain peptide-related impurities or other contaminants.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSterility Risks:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Unverified injectable formulations may present contamination and infection risks.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUnknown Systemic Effects:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Long-term effects on cellular signaling, angiogenesis, and tissue remodeling remain insufficiently characterized.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUncharacterized Interactions:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e The biological consequences of combining BPC-157 and TB-500 have not been adequately evaluated.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eLimited Clinical Evidence:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e There is insufficient evidence to establish safe human administration or therapeutic effectiveness.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThe safety of either peptide cannot be assumed to establish the safety of their combination.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Use Only\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eFOR SCIENTIFIC AND LABORATORY RESEARCH PURPOSES ONLY.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for qualified professionals conducting legitimate scientific investigations in peptide pharmacology, cellular biology, and regenerative research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eNot approved for human or veterinary use. Not intended for injection, ingestion, self-administration, bodybuilding enhancement, injury treatment, or unauthorized therapeutic applications.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNot intended to diagnose, treat, cure, or prevent any disease.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch-use labeling does not constitute pharmaceutical approval or authorization for clinical administration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePEPTITAN — PRECISION. SCIENCE. RESEARCH.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":59502137377032,"sku":null,"price":170.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1078\/2942\/8488\/files\/Frasco_de_Vidro_com_Arcos_Dourados.png?v=1794657660","url":"https:\/\/peptgrind.com\/products\/bpc157-10mg-tb500-10-mg","provider":"peptitan","version":"1.0","type":"link"}